What is the point of having a great GDP if as a society we are unhealthy? I am a bit of a dreamer. I dream that one day we will be living in a country where things will be different, and where the rich and the poor will both get the same, good, quality health care. To many it may seem like a totally impractical, and an unachievable dream. But it's...
More »SEARCH RESULT
Total Matching Records found : 275
The government needs to think out of the box to help pharma grow while keeping medicines affordable-Ramesh Adige
Having watched from the ringside for many years now, I have no doubt in advising that the steering wheel must be firmly grasped by the government and direction given to policies that should be stable for at least the medium term. This is crucial for the growth of Indian pharma, a $20-billion industry growing at an average of 12% considering both domestic and export arenas. Price control: The biggest and most...
More »A healthier India: Need to resolve conflict between drug price controls, innovation and affordable healthcare-David Taylor
The debate about essential-medicine pricing and access in India illustrates the difficulties inherent in establishing policies that serve conflicting public interests in achieving goals such as caring well and ensuring safety for all, while also pursuing financially-sustainable success in scientific innovation and trade. It highlights problems facing those interested in continuing drug and vaccines development and ensuring that, once marketed, such products contribute effectively to improving public health. Modern pharmaceuticals...
More »Bayer to challenge Cipla’s decision to cut price of cancer drug
-PTI German pharma major Bayer has charged that Indian generic drugmaker Cipla had breached its patent rights by slashing the price of a generic version of its patent-protected cancer drug Nexavar last week. Bayer Pharma has not given its consent to Cipla to launch its generic Sorafenib (sold under the brand name Nexavar) and the company’s decision to cut the price of the life-extending kidney and liver cancer drug “is a clear...
More »New UN-backed report calls for action to prevent millions of preterm births
-The United Nations Some 15 million babies worldwide – more than one in ten births – are born too early, according to a new United Nations-backed report, released today, which calls for steps such as ensuring the requisite medicines and equipment and training health staff to promote child survival. “All newborns are vulnerable, but preterm babies are acutely so,” says Secretary General Ban Ki-moon, who wrote the foreword to the report, entitled...
More »
